PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to stop the itch-scratch cycle of prurigo nodularis
Symptom relief Recruiting nowThis study tests an experimental drug called povorcitinib for people with prurigo nodularis, a condition causing intense itching and many skin bumps. About 330 adults aged 18 to 75 with moderate to severe symptoms will receive either the drug or a placebo. The goal is to see if t…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 26, 2026 04:00 UTC
-
New study tests nemolizumab for severe itch in Real-World patients
Symptom relief Recruiting nowThis study looks at how well the drug nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. Researchers will track 600 patients over 6 to 12 months to see if their itch and skin lesions improve. The goal is…
Matched conditions: PRURIGO NODULARIS
Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 26, 2026 03:59 UTC
-
New hope for kids with relentless itchy skin bumps?
Symptom relief Recruiting nowThis study tests the safety and processing of dupilumab in 18 children and teens (6 months to under 18 years) with prurigo nodularis, a condition causing very itchy skin bumps. Participants receive the drug for 24 weeks and are monitored for side effects and how the drug moves th…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
New shot aims to stop the maddening itch of prurigo nodularis
Symptom relief Recruiting nowThis study tests an experimental drug called SHR-1819, given as an injection, to see if it can safely reduce the intense itching caused by prurigo nodularis—a skin condition with hard, itchy bumps. About 423 adults will receive either the drug or a placebo, and researchers will t…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
New drug BGB-45035 enters first human trials for eczema and skin nodules
Symptom relief Recruiting nowThis study tests a new drug called BGB-45035 for the first time in humans. It will check safety and how the body processes the drug in healthy volunteers, then test it in people with autoimmune skin diseases like eczema and prurigo nodularis. The goal is to see if the drug is saf…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE1 • Sponsor: BeiGene • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC